Endovia Health Sciences, Inc. (EDVA) — SEC Financial Statements & Analysis

Endovia Health Sciences, Inc. (EDVA) is a beverages company, incorporated in NV. Endovia Health Sciences, Inc. trades on NYSE as: EDVA, SBEV. Endovia Health Sciences, Inc. (EDVA)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-19. Based on that filing, Endovia Health Sciences, Inc. carries a market cap of $1.90M, a P/E ratio of -0.11x, a P/B ratio of -0.12x, a P/S ratio of 13.72x, an enterprise value of $7.66M, and an EV/EBITDA multiple of -0.55x. On profitability, it posts a gross margin of 3.86%, an operating margin of -3236.85%, a net margin of -5757.80%, a Return on Equity (ROE) of 127.87%, a Return on Assets (ROA) of -148.26%, and a Return on Invested Capital (ROIC) of -221.89%. Per share, it reports EPS of $-5.64, diluted EPS of $-5.64, free cash flow per share of $-1.79, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of -100.00% year-over-year, net income growth of -44.66% year-over-year, and EPS growth of -91.42% year-over-year. On the balance sheet, it maintains a current ratio of 0.05x, a quick ratio of 0.04x, working capital of $-15.92M, a debt-to-equity ratio of -1.07x, a debt ratio of 15.63, an interest coverage ratio of -5.88x, free cash flow of $-5.48M (TTM), and net debt of $5.76M. Figures sourced from SEC EDGAR.

Market Cap

$1.90M

P/E TTM

-0.11x

EPS TTM

$-5.64

P/B TTM

-0.12x

ROE TTM

127.87%

ROA TTM

-148.26%

Debt To Equity

-1.07x

Free Cash Flow TTM

$-5.48M

Net Revenue TTM Growth 1Y

-100.00%

Data as of 2026-06-30 · Source: SEC EDGAR